SCHEMBL7711230

SCHEMBL7711230

CC1Oc2ccc(Br)cc2NC1=S

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 4/20 0.37
PDE3B Q13370 2/20 0.36
PDE3A Q14432 2/20 0.36
PBRM1 Q86U86 1/20 0.36
BRD4 O60885 1/20 0.35
CREBBP Q92793 1/20 0.35
AHR P35869 4/20 0.34
AKR1B1 P15121 1/20 0.33
ADRA2A P08913 1/20 0.33
PNMT P11086 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
CHRM1 P11229 1/20 0.32
SMYD3 Q9H7B4 1/20 0.32
BACE1 P56817 2/20 0.32
CMA1 P23946 1/20 0.31
GABRA1 P14867 1/20 0.31
GABRA5 P31644 1/20 0.31
GABRA3 P34903 1/20 0.31
GABRA2 P47869 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988135 0.81 BRD4 (0.53) PARP1BRD4CREBBP
SCHEMBL16823716 0.80 PARP1 (0.60) PARP1PDE3BPDE3APBRM1BRD4
SCHEMBL531756 0.80 PARP1 (0.60) PARP1PDE3BPDE3APBRM1BRD4
SCHEMBL7000474 0.80 PARP1 (0.37) PARP1PDE3BPDE3ABRD4CREBBP
SCHEMBL7984345 0.80 HSD17B10 (0.43) PARP1PDE3BPDE3ABRD4CREBBP
SCHEMBL7981172 0.78 PARP1 (0.35) PARP1PDE3BPDE3ABRD4CREBBP
SCHEMBL6995122 0.76 ABCB1 (0.38) PARP1PDE3BPDE3ABRD4CREBBP
SCHEMBL6998842 0.76 ACE2 (0.40) PARP1BRD4CREBBPCHRM1
SCHEMBL7000985 0.76 KDM4E (0.54) PARP1PDE3BPDE3ACHRM1
SCHEMBL6996429 0.74 ALDH1A1 (0.40) AKR1B1ADRA2APNMTADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed